Vertex Progresses with VX-950
Vertex is the racehorse to watch right now. They are progressing quicky on their preliminary good results. While it’s not... View Article
Continue reading »Hepatitis C Treatments/Therapies
Pill Form of Therapy for HCV Coming Closer
Nov 19, 2005
2 Comments
This report is an update of therapy progress presented at the AASLD (American Academy for the Study of Liver Diseases).... View Article
Continue reading »HCV Vaccine Progress
The development of a HCV vaccine is very exciting, even to patients already infected. Although the vaccine will not help them direcly, it shows definite progress in understanding and outsmarting this virus that is known to be difficult to combat due to its rapid mutation. If they are making progress with a vaccine, progress for better treatment must be close behind.
Continue reading »Japanese Researchers Make Progress
This article is from one of the largest Japanese newspapers. As it shows, researchers in Japan are also working hard to develop a better treatment for HCV. Scientists the world over are doing their best to find a less toxic and more effective treatment.
Continue reading »VX-950 Making Progress
Here’s an exciting one, VX-950 we’ve been watching for a while. This protease inhibitor is making good progress (and is... View Article
Continue reading »Another Biotech Contender
Here is another compound from a biotech pharmaceutical company. This antisense approach has been spoken of with great promise. We look forward to seeing how it proceeds. We'll stay tuned to this one...
Continue reading »Zandaxin Announcement December 2005
Phase 3 Trials are very advanced. If it works, Zandaxin is another enhancement for Interferon therapy. We are looking forward to alternatives to Interferon therapy, but this could be a very positive advance for patients who would consider Interferon and benefit from it. Especially considering that these tests are focused on non-responders, who currently have little recourse but to protect and support their livers with clinically proven natural approaches.
Continue reading »New Drug, Actilon, In Development
Another new approach in the pipeline. As we've always said, with millions of people infected, the drug and biotech companies are falling over each other to come up with viable treatments to improve on what is currently available.
Continue reading »Another Treatment Development Alliance
Alnylam to align with West Coast firm on hep C treatment Boston Business Journal Alnylam Pharmaceuticals Inc. and a California... View Article
Continue reading »TLR7 Agonist against HCV
Wow. Another promising candidate for more effective (and less toxic) HCV treatment. We’ll keep you posted on this one, as... View Article
Continue reading »
